Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
The American Journal of Pathology
|
May 3, 2006
Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy
Tara L Spires, Jennifer D Orne, Karen SantaCruz, et al.
Nature
|
April 2, 2010
Caspase activation precedes and leads to tangles
Alix de Calignon, Leora M Fox, Rose Pitstick, et al.
Journal of Neuropathology and Experimental Neurology
|
June 14, 2011
Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model
Leora M Fox, Christopher M William, David H Adamowicz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 2017
Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice
Noah R Johnson, Carlo Condello, Shenheng Guan, et al.
Plos One
|
February 6, 2013
Levels of the Mahogunin Ring Finger 1 E3 ubiquitin ligase do not influence prion disease
Derek Silvius, Rose Pitstick, Misol Ahn, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
August 10, 2011
The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model
Xiqian Lan, Tomomi Kiyota, Richa Hanamsagar, et al.
The Journal of Comparative Neurology
|
October 11, 2012
Synaptic alterations in the rTg4510 mouse model of tauopathy
Katherine J Kopeikina, Manuela Polydoro, Hwan-Ching Tai, et al.
Plos One
|
November 27, 2013
Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy
Katherine J Kopeikina, Susanne Wegmann, Rose Pitstick, et al.
Acta Neuropathologica Communications
|
November 22, 2017
A novel vector for transgenesis in the rat CNS
T Peter Lopez, Kurt Giles, Brittany N Dugger, et al.
Neuropharmacology
|
December 12, 2013
Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy
Danielle L Graham, Audrey J Gray, John A Joyce, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
The American Journal of Pathology
|
May 3, 2006
Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy
Tara L Spires, Jennifer D Orne, Karen SantaCruz, et al.
Nature
|
April 2, 2010
Caspase activation precedes and leads to tangles
Alix de Calignon, Leora M Fox, Rose Pitstick, et al.
Journal of Neuropathology and Experimental Neurology
|
June 14, 2011
Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model
Leora M Fox, Christopher M William, David H Adamowicz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 2017
Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice
Noah R Johnson, Carlo Condello, Shenheng Guan, et al.
Plos One
|
February 6, 2013
Levels of the Mahogunin Ring Finger 1 E3 ubiquitin ligase do not influence prion disease
Derek Silvius, Rose Pitstick, Misol Ahn, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
August 10, 2011
The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model
Xiqian Lan, Tomomi Kiyota, Richa Hanamsagar, et al.
The Journal of Comparative Neurology
|
October 11, 2012
Synaptic alterations in the rTg4510 mouse model of tauopathy
Katherine J Kopeikina, Manuela Polydoro, Hwan-Ching Tai, et al.
Plos One
|
November 27, 2013
Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy
Katherine J Kopeikina, Susanne Wegmann, Rose Pitstick, et al.
Acta Neuropathologica Communications
|
November 22, 2017
A novel vector for transgenesis in the rat CNS
T Peter Lopez, Kurt Giles, Brittany N Dugger, et al.
Neuropharmacology
|
December 12, 2013
Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy
Danielle L Graham, Audrey J Gray, John A Joyce, et al.
Page
of 8